Design of multi-epitope, analogue-based cancer vaccines.

Design of multi-epitope, analogue-based cancer vaccines.

Item
http://www.wikidata.org/entity/Q35207535
Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell DeterminantStructural and Functional Correlates of Enhanced Antiviral Immunity Generated by Heteroclitic CD8 T Cell EpitopesHLA class I supertypes: a revised and updated classification.DNA vaccines: ready for prime time?Antitumor cytotoxic T-cell response induced by a survivin peptide mimicChallenges in the development of a survivin vaccine (SurVaxM) for malignant glioma.Novel vaccines for glioblastoma: clinical update and perspective.BCR-ABL fusion regions as a source of multiple leukemia-specific CD8+ T-cell epitopes.Immunodominance of CD4 T cells to foreign antigens is peptide intrinsic and independent of molecular context: implications for vaccine design.Development of a novel clustering tool for linear peptide sequences
P2860

Design of multi-epitope, analogue-based cancer vaccines.

Item
http://www.wikidata.org/entity/Q35207535
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Design of multi-epitope, analogue-based cancer vaccines.
@ast
Design of multi-epitope, analogue-based cancer vaccines.
@en
type
label
Design of multi-epitope, analogue-based cancer vaccines.
@ast
Design of multi-epitope, analogue-based cancer vaccines.
@en
prefLabel
Design of multi-epitope, analogue-based cancer vaccines.
@ast
Design of multi-epitope, analogue-based cancer vaccines.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Design of multi-epitope, analogue-based cancer vaccines.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698